首页> 外国专利> IMPLANTABLE MEDICAL SYSTEMS, DEVICES, AND METHODS FOR AFFECTING CARDIAC FUNCTION THROUGH DIAPHRAGM STIMULATION, AND FOR MONITORING DIAPHRAGMATIC HEALTH

IMPLANTABLE MEDICAL SYSTEMS, DEVICES, AND METHODS FOR AFFECTING CARDIAC FUNCTION THROUGH DIAPHRAGM STIMULATION, AND FOR MONITORING DIAPHRAGMATIC HEALTH

机译:通过隔膜刺激来影响心脏功能的植入医疗系统,装置和方法,并用于监测膈肌健康

摘要

Devices, systems and methods provide forms of asymptomatic diaphragmatic stimulation (ADS) therapy that affect pressures within the intrathoracic cavity, including: 1) dual-pulse ADS therapy, during which a first ADS pulse is delivered during a diastolic phase of a cardiac cycle and a second ADS pulse is delivered during a systolic phase, 2) paired-pulse ADS therapy, during which a first ADS pulse is delivered, closely followed by a second ADS pulse, with the second ADS pulse functioning to extend or enhance a phase of a transient, partial contraction of the diaphragm, and 3) multiple-pulse ADS therapy, during which a stream of ADS pulses is delivered, wherein the time between pulses is based on heart rate. Devices, systems and methods also monitor electromyography (EMG) activity of the diaphragm relative to baseline activity to assess the health of a diaphragm subject to ADS therapy and to adjust ADS therapy parameters or sensing parameters.
机译:器件,系统和方法提供了影响含有:1)双脉冲腔内的压力的无症状膈肌刺激(ADs)治疗的形式,包括:1)双脉冲ADS治疗,在此期间在心脏周期的舒张相期间递送第一ADS脉冲在收缩期相位,2)配对脉冲ADS治疗期间递送第二广告脉冲,在此期间递送第一ADS脉冲,接近第二个ADS脉冲,第二个ADS脉冲功能延伸或增强a的相位膈肌的瞬态,部分收缩和3)多脉冲ADS治疗,在此期间递送ADS脉冲流,其中脉冲之间的时间基于心率。器件,系统和方法还可以监测相对于基线活动的膈肌(EMG)活性,以评估视膜的健康受ADS治疗,并调整ADS治疗参数或感测参数。

著录项

  • 公开/公告号US2021093856A1

    专利类型

  • 公开/公告日2021-04-01

    原文格式PDF

  • 申请/专利权人 VISCARDIA INC.;

    申请/专利号US202017029806

  • 发明设计人 PETER T. BAUER;TIMOTHY WHEELER;

    申请日2020-09-23

  • 分类号A61N1/36;A61N1/05;A61N1/365;A61N1/08;

  • 国家 US

  • 入库时间 2022-08-24 18:01:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号